Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
49 drugs for “Metastatic”
Approved 12
- RelacorilantCORCEPT THERAPEUTICS INCMetastatic Pancreatic Ductal Adenocarcinoma · next catalyst 17 Dec 2026
- CapivasertibASTRAZENECA PLCLocally Advanced (Inoperable) or Metastatic Breast Cancer; Locally Advanced or Metastatic Breast Cancer
- CosibelimabCheckpoint Therapeutics, Inc.Metastatic Non-squamous Non Small Cell Lung Cancer
- DaraxonrasibRevolution Medicines, Inc.Pancreatic Adenocarcinoma Metastatic
- NeratinibPUMA BIOTECHNOLOGY, INC.HER2+ Metastatic Breast Cancer (MBC)
- PalbociclibPFIZER INCMetastatic Breast Cancer
- PemigatinibINCYTE CORPMetastatic Cholangiocarcinoma
- RetifanlimabINCYTE CORPMetastatic Nonsquamous Non-Small Cell Lung Cancer; Metastatic Squamous Non-Small Cell Lung Cancer
- RibociclibNOVARTIS AGAdvanced Metastatic Breast Cancer; Advanced, Metastatic Breast Cancer
- SelumetinibASTRAZENECA PLCLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV; Metastatic
- SotorasibAMGEN INCMetastatic Colorectal Cancer
- TremelimumabASTRAZENECA PLCMetastatic Urothelial Cancer
Phase 3 25
- IvonescimabSummit Therapeutics Inc.Metastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC) · next catalyst 14 Nov 2026
- AcasunlimabGENMAB A/SPD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
- Actinium zadavotide guraxetanASTRAZENECA PLCMetastatic Castration-resistant Prostate Cancer
- AtebimetinibImmuneering CorpPancreatic Adenocarcinoma Metastatic
- AZD9291ASTRAZENECA PLCLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
- BNT324BioNTech SEMetastatic Castration-resistant Prostate Cancer
- CasdatifanArcus Biosciences, Inc.Metastatic Clear Cell Renal Cell Carcinoma
- CeralasertibASTRAZENECA PLCAdvanced or Metastatic Non-Small Cell Lung Cancer
- CGT9486Cogent Biosciences, Inc.Metastatic Cancer
- Eftilagimod alfaIMMUTEP LtdAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- FirmonertinibArriVent BioPharma, Inc.Metastatic Non-Small-Cell Lung Cancer
- FurmonertinibArriVent BioPharma, Inc.Metastatic Non-Small Cell Lung Cancer
- MevrometostatPFIZER INCMetastatic Castration Sensitive Prostate Cancer (mCSPC)
- MRTX849Mirati Therapeutics, Inc.Metastatic Colorectal Cancer; Metastatic Non Small Cell Lung Cancer
- NaporafenibErasca, Inc.Advanced or Metastatic NRAS-mutant Melanoma
- NIS793NOVARTIS AGMetastatic Pancreatic Ductal Adenocarcinoma
- OpevesostatMerck & Co., Inc.Metastatic Castration-resistant Prostate Cancer (mCRPC); Prostate Cancer Metastatic
- PalazestrantOlema Pharmaceuticals, Inc.Metastatic Breast Cancer
- PumitamigBRISTOL MYERS SQUIBB COUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma; Untreated, Unresectable, or Metastatic Colorectal Cancer
- QuemliclustatArcus Biosciences, Inc.Metastatic Pancreatic Ductal Adenocarcinoma
- RinzimetostatOric Pharmaceuticals, Inc.Metastatic Castration Resistant Prostate Cancer
- SaruparibASTRAZENECA PLCMetastatic Castration-Sensitive Prostate Cancer; Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- TAK-788TAKEDA PHARMACEUTICAL CO LTDAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Telisotuzumab adizutecanAbbVie Inc.Metastatic Pancreatic Ductal Adenocarcinoma
- VeliparibAbbVie Inc.Metastatic Breast Cancer
Phase 2/3 7
- BMS-986504BRISTOL MYERS SQUIBB COMetastatic Non-small Cell Lung Cancer With MTAP Deletion
- BNT113BioNTech SEMetastatic Head and Neck Cancer
- Ficerafusp alfaBicara Therapeutics Inc.Metastatic Head and Neck Squamous Cell Carcinoma
- IDE196IDEAYA Biosciences, Inc.Metastatic Uveal Melanoma
- Ivonescimab RP3DSummit Therapeutics Inc.Metastatic Urothelial Carcinoma; Metastatic Urothelial Carcinoma (UC)
- PonsegromabPFIZER INCMetastatic Pancreatic Ductal Adenocarcinoma
- SBP-101Panbela Therapeutics, Inc.Pancreatic Cancer Metastatic
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.